Macroaxis: Personalized Investing

Personalized Investing and

Digital Wealth Optimization

Benchmark  United States  NYSE  11,063   19.31 Index Moved Down -0.17%  

Collecting data for ONVO

Organovo price prediction Organovo price prediction

Investment horizon:  
  30 Days    Login   to change
With this exotic module your can estimate the sentimental value of Organovo Holdings Inc from the prospective of Organovo response to recently generated media hype and the effects of current headlines on its competitors. The module also provides analysis of price elasticity to changes in media outlook on Organovo over a specific investment horizon. See also Organovo Backtesting, Organovo Volatility, Organovo Valuation, Organovo Correlation, Organovo History and Organovo Performance

Organovo hype analysis

Daily Expected returnPeriod VolatilityHype elasticityRelated hype elasticityAverage news densityRelated news densityNext Expected Hype
Price Moved Down 0.38% 1.74%Price Moved Down 0.03% Price Moved Up 0.22% 1 Events / Month2 Events / MonthUncertain
Latest traded priceExpected after-news pricePotential return on next major newsAverage after-hype volatility
5.925.890.51% Organovo price prediction down

Organovo estimiated after-hype price volatility

Next price density
Expected price to next headline
March 1, 2015
Current Value
Downside upside
After-hype Price
Upside upside
Organovo is relatively volatile asset. Analysis and calculation of next after-hype price of Organovo Holdings is based on 1 month time horizon.

Organovo hype timeline

Organovo Holdings Inc is now traded for 5.92 . This company has historical hype elasticity of -0.03 and average elasticity to hype of competition of 0.22. Organovo Holdings Inc is projected to decline in value after the next headline with price expected to drop to 5.89. The average volatility of media hype impact on the company stock price is about 1933.33%. The price decrease on the next news is expected to be -0.51% where as daily expected return is now at -0.38%. The volatility of related hype on Organovo is about 300.0% with expected price after next announcement by competition of 6.14. About 20.0% of the company shares are owned by institutional investors. The company recorded loss per share of 0.35. Organovo Holdings Inc had not issued any dividends in recent years. Given the investment horizon of 30 days, the next projected press release will be uncertain.
See also Organovo Backtesting, Organovo Volatility, Organovo Valuation, Organovo Correlation, Organovo History and Organovo Performance
Organovo Value 
Benchmark  Embed   Timeline 

Organovo related hype analysis

Short fall
At Risk
Thermo Fisher Scientific Inc 0.15 3 per month 0.00  0.0044  0.00  2.65 (2.15) 6.00 
Agilent Technologies Inc(0.31)2 per month 0.00  0.14  0.00  2.44 (1.79) 3.90 
Quest Diagnostics Inc(0.56)2 per month 0.00 (0.18) 0.00  1.52 (1.35) 5.91 
Laboratory Corp of America Holdings 0.11 2 per month 0.00  0.06  0.00  1.72 (1.19) 4.55 
Quintiles Transnational Holdings Inc 0.50 2 per month 0.00  0.05  0.00  1.47 (1.71) 5.00 
Covance Inc 0.92 1 per month 0.00 (0.32) 0.00  0.59 (0.66) 1.68 
PerkinElmer Inc(0.41)2 per month 0.00  0.09  0.00  1.89 (1.13) 5.60 
ICON Public Limited Company(0.42)2 per month 0.00  0.28  0.00  3.87 (1.25) 10.69 
Alere Inc 0.55 2 per month 0.00  0.16  0.00  2.74 (1.50) 6.43 
BioRad Laboratories Inc 5.27 1 per month 0.00  0.20  0.00  1.34 (0.64) 2.04 


Risk Adjusted Returns Landscape
Live Efficient Frontier
Market Correlation Analysis
Watchlist Analysis
Financial Content
Portfolio Estimation and Projections
Portfolio Theme Builder

Research Modules

Equities Backtesting Analysis
Instant Retirement Optimizer
Cross-portfolio RSS and Mobile Access
Company, fund, and ETF Directory
Financial Advisor Directory
Insider and Manager Directory
Wealth Management

Services And Technology

Frequently Asked Questions
Quick Product Tour
Product Technology Overview
Solution Methodology
Plans and Pricing

Free Investor Tools

World Market Correlations
Instant Equity Comparator
Watchlist Analysis
Position Suggestions
Equity Alpha Analysis

About Us

About Macroaxis
Contact Us
Product Terms Of Use
Service Privacy Policy
Advertising Opportunities